Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin

Nucleic Acids Research

Volumn 40, Issue 10, 2012, Pages 4368-4384

  Ortells, M Carmen ^a   Morancho, Beatriz ^a,f   Drews Elger, Katherine ^a,g   Viollet, Benoit ^b,c,d   Laderoute, Keith R ^e   López Rodríguez, Cristina ^a   Aramburu, Jose ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUT COCHIN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SRI INTERNATIONAL   (United States)

^f VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^g UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H4; HYPERTONIC SOLUTION; MAMMALIAN TARGET OF RAPAMYCIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT 5; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELLULAR STRESS RESPONSE; ENZYME ACTIVITY; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE INTERACTION; GENE TARGETING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MAMMAL CELL; NUCLEOTIDE SEQUENCE; OSMOTIC STRESS; PRIORITY JOURNAL; REDD1 GENE; REDD2 GENE; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; CHROMATIN; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION; HUMANS; MICE; NFATC TRANSCRIPTION FACTORS; OSMOTIC PRESSURE; STRESS, PHYSIOLOGICAL; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 84861563571     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks038     Document Type: Article

References (100)

1. Fingar, D.C. and Blenis, J. (2004) Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene, 23, 3151-3171.
2. Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell, 110, 163-175.
3. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J. and Yonezawa, K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell, 110, 177-189.
4. Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol., 14, 1296-1302.
5. Yang, Q., Inoki, K., Ikenoue, T. and Guan, K.L. (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev., 20, 2820-2832.
6. Lee-Fruman, K.K., Kuo, C.J., Lippincott, J., Terada, N. and Blenis, J. (1999) Characterization of S6K2, a novel kinase homologous to S6K1. Oncogene, 18, 5108-5114.
7. Hara, K., Yonezawa, K., Kozlowski, M.T., Sugimoto, T., Andrabi, K., Weng, Q.P., Kasuga, M., Nishimoto, I. and Avruch, J. (1997) Regulation of eIF-4E BP1 phosphorylation by mTOR. J. Biol. Chem., 272, 26457-26463.
8. Peng, T., Golub, T.R. and Sabatini, D.M. (2002) The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol., 22, 5575-5584.
9. Grolleau, A., Bowman, J., Pradet-Balade, B., Puravs, E., Hanash, S., Garcia-Sanz, J.A. and Beretta, L. (2002) Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem., 277, 22175-22184.
10. James, M.J. and Zomerdijk, J.C. (2004) Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients. J. Biol. Chem., 279, 8911-8918.
11. Jimenez, R.H., Lee, J.S., Francesconi, M., Castellani, G., Neretti, N., Sanders, J.A., Sedivy, J. and Gruppuso, P.A. (2010) Regulation of gene expression in hepatic cells by the mammalian target of rapamycin (mTOR). PLoS One, 5, e9084.
12. Duvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S. et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell, 39, 171-183.
13. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M.A., Hall, A. and Hall, M.N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol., 6, 1122-1128.
14. Powell, J.D. and Delgoffe, G.M. (2010) The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity, 33, 301-311.
15. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S.Y., Huang, Q., Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates akt phosphorylation and substrate specificity. Cell, 127, 125-137.
16. Oh, W.J., Wu, C.C., Kim, S.J., Facchinetti, V., Julien, L.A., Finlan, M., Roux, P.P., Su, B. and Jacinto, E. (2010) mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent akt polypeptide. EMBO J., 29, 3939-3951.
17. Choo, A.Y., Yoon, S.O., Kim, S.G., Roux, P.P. and Blenis, J. (2008) Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc. Natl Acad. Sci. USA, 105, 17414-17419.
18. Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y., Reichling, L.J., Sim, T., Sabatini, D.M. and Gray, N.S. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem., 284, 8023-8032.
19. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., Markhard, A.L. and Sabatini, D.M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell, 22, 159-168.
20. Corradetti, M.N. and Guan, K.L. (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene, 25, 6347-6360.
21. Budanov, A.V. and Karin, M. (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell, 134, 451-460.
22. Corradetti, M.N., Inoki, K., Bardeesy, N., DePinho, R.A. and Guan, K.L. (2004) Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev., 18, 1533-1538.
23. Inoki, K., Li, Y., Xu, T. and Guan, K.L. (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev., 17, 1829-1834.
24. Inoki, K., Zhu, T. and Guan, K.L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell, 115, 577-590.
25. Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., Turk, B.E. and Shaw, R.J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell, 30, 214-226.
26. Choo, A.Y., Kim, S.G., Vander Heiden, M.G., Mahoney, S.J., Vu, H., Yoon, S.O., Cantley, L.C. and Blenis, J. (2010) Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol. Cell, 38, 487-499.
27. Lee, C.H., Inoki, K., Karbowniczek, M., Petroulakis, E., Sonenberg, N., Henske, E.P. and Guan, K.L. (2007) Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J., 26, 4812-4823.
28. Land, S.C. and Tee, A.R. (2007) Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J. Biol. Chem., 282, 20534-20543.
29. Toschi, A., Lee, E., Gadir, N., Ohh, M. and Foster, D.A. (2008) Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J. Biol. Chem., 283, 34495-34499.
30. Burg, M.B., Ferraris, J.D. and Dmitrieva, N.I. (2007) Cellular response to hyperosmotic stresses. Physiol. Rev., 87, 1441-1474.
31. Machnik, A., Neuhofer, W., Jantsch, J., Dahlmann, A., Tammela, T., Machura, K., Park, J.K., Beck, F.X., Muller, D.N., Derer, W. et al. (2009) Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med., 15, 545-552.
32. Boucher, R.C., Stutts, M.J., Bromberg, P.A. and Gatzy, J.T. (1981) Regional differences in airway surface liquid composition. J. Appl. Physiol., 50, 613-620.
33. Chuang, A.I. and Ito, S. (2010) Ambient tonicity and intestinal cytochrome CYP3A. Expert Opin. Drug Metab. Toxicol., 6, 883-893.
34. Dmitrieva, N.I. and Burg, M.B. (2005) Hypertonic stress response. Mutat. Res., 569, 65-74.
35. Cooke, C.R., Wall, B.M., Jones, G.V., Presley, D.N. and Share, L. (1993) Reversible vasopressin deficiency in severe hypernatremia. Am. J. Kidney Dis., 22, 44-52.
36. Papadimitriou, A., Kipourou, K., Manta, C., Tapaki, G. and Philippidis, P. (1997) Adipsic hypernatremia syndrome in infancy. J. Pediatr. Endocrinol. Metab., 10, 547-550.
37. McDill, B.W., Li, S.Z., Kovach, P.A., Ding, L. and Chen, F. (2006) Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation. Proc. Natl Acad. Sci. USA, 103, 6952-6957.
38. Ma, T., Yang, B., Gillespie, A., Carlson, E.J., Epstein, C.J. and Verkman, A.S. (1998) Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J. Biol. Chem., 273, 4296-4299.
39. Loyher, M.L., Mutin, M., Woo, S.K., Kwon, H.M. and Tappaz, M.L. (2004) Transcription factor tonicity-responsive enhancer-binding protein (TonEBP) which transactivates osmoprotective genes is expressed and upregulated following acute systemic hypertonicity in neurons in brain. Neuroscience, 124, 89-104.
40. Berga-Bolanos, R., Drews-Elger, K., Aramburu, J. and Lopez-Rodriguez, C. (2010) NFAT5 regulates T lymphocyte homeostasis and CD24-dependent T cell expansion under pathologic hypernatremia. J. Immunol., 185, 6624-6635.
41. Kultz, D. and Chakravarty, D. (2001) Maintenance of genomic integrity in mammalian kidney cells exposed to hyperosmotic stress. Comp. Biochem. Physiol. A. Mol. Integr. Physiol., 130, 421-428.
42. Dmitrieva, N., Kultz, D., Michea, L., Ferraris, J. and Burg, M. (2000) Protection of renal inner medullary epithelial cells from apoptosis by hypertonic stress-induced p53 activation. J. Biol. Chem., 275, 18243-18247.
43. Sheen, M.R., Kim, S.W., Jung, J.Y., Ahn, J.Y., Rhee, J.G., Kwon, H.M. and Woo, S.K. (2006) Mre11-Rad50-Nbs1 complex is activated by hypertonicity. Am. J. Physiol. Renal Physiol., 291, F1014-F1020.
44. Drews-Elger, K., Ortells, M.C., Rao, A., Lopez-Rodriguez, C. and Aramburu, J. (2009) The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress. PLoS One, 4, e5245.
45. Dmitrieva, N.I., Michea, L.F., Rocha, G.M. and Burg, M.B. (2001) Cell cycle delay and apoptosis in response to osmotic stress. Comp Biochem. Physiol A Mol. Integr. Physiol., 130, 411-420.
46. Lopez-Rodriguez, C., Antos, C.L., Shelton, J.M., Richardson, J.A., Lin, F., Novobrantseva, T.I., Bronson, R.T., Igarashi, P., Rao, A. and Olson, E.N. (2004) Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc. Natl Acad. Sci. USA, 101, 2392-2397.
47. Go, W.Y., Liu, X., Roti, M.A., Liu, F. and Ho, S.N. (2004) NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl Acad. Sci. USA, 101, 10673-10678.
48. Lee, S.D., Choi, S.Y., Lim, S.W., Lamitina, S.T., Ho, S.N., Go, W.Y. and Kwon, H.M. (2011) TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and-independent pathways. Am. J. Physiol. Renal Physiol., 300, F707-F715.
49. Miyakawa, H., Woo, S.K., Dahl, S.C., Handler, J.S. and Kwon, H.M. (1999) Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA, 96, 2538-2542.
50. Lopez-Rodriguez, C., Aramburu, J., Rakeman, A.S. and Rao, A. (1999) NFAT5, a constitutively nuclear NFAT protein that does not cooperate with fos and jun. Proc. Natl Acad. Sci. USA, 96, 7214-7219.
51. Lopez-Rodriguez, C., Aramburu, J., Jin, L., Rakeman, A.S., Michino, M. and Rao, A. (2001) Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity, 15, 47-58.
52. Woo, S.K., Lee, S.D., Na, K.Y., Park, W.K. and Kwon, H.M. (2002) TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity. Mol. Cell. Biol., 22, 5753-5760.
53. Kojima, R., Randall, J.D., Ito, E., Manshio, H., Suzuki, Y. and Gullans, S.R. (2004) Regulation of expression of the stress response gene, Osp94: identification of the tonicity response element and intracellular signalling pathways. Biochem. J., 380, 783-794.
54. Ito, T., Fujio, Y., Hirata, M., Takatani, T., Matsuda, T., Muraoka, S., Takahashi, K. and Azuma, J. (2004) Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells. Biochem. J., 382, 177-182.
55. Nakayama, Y., Peng, T., Sands, J.M. and Bagnasco, S.M. (2000) The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression. J. Biol. Chem., 275, 38275-38280.
56. Ito, T., Fujio, Y., Takahashi, K. and Azuma, J. (2007) Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes. J. Biol. Chem., 282, 1152-1160.
57. Parrott, L.A. and Templeton, D.J. (1999) Osmotic stress inhibits p70/85 S6 kinase through activation of a protein phosphatase. J. Biol. Chem., 274, 24731-24736.
58. Chen, D., Fucini, R.V., Olson, A.L., Hemmings, B.A. and Pessin, J.E. (1999) Osmotic shock inhibits insulin signaling by maintaining Akt/protein kinase B in an inactive dephosphorylated state. Mol. Cell. Biol., 19, 4684-4694.
59. Naegele, S. and Morley, S.J. (2004) Molecular cross-talk between MEK1/2 and mTOR signaling during recovery of 293 cells from hypertonic stress. J. Biol. Chem., 279, 46023-46034.
60. Van der Kaay, J., Beck, M., Gray, A. and Downes, C.P. (1999) Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses. J. Biol. Chem., 274, 35963-35968.
61. Barnes, K., Ingram, J.C., Porras, O.H., Barros, L.F., Hudson, E.R., Fryer, L.G., Foufelle, F., Carling, D., Hardie, D.G. and Baldwin, S.A. (2002) Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell. Sci., 115, 2433-2442.
62. Hawley, S.A., Ross, F.A., Chevtzoff, C., Green, K.A., Evans, A., Fogarty, S., Towler, M.C., Brown, L.J., Ogunbayo, O.A., Evans, A.M. et al. (2010) Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell. Metab., 11, 554-565.
63. Irarrazabal, C.E., Burg, M.B., Ward, S.G. and Ferraris, J.D. (2006) Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: role in osmoprotective transcriptional regulation. Proc. Natl Acad. Sci. USA, 103, 8882-8887.
64. Morancho, B., Minguillon, J., Molkentin, J.D., Lopez-Rodriguez, C. and Aramburu, J. (2008) Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Mol. Biol., 9, 13.
65. Crespo, J.L., Daicho, K., Ushimaru, T. and Hall, M.N. (2001) The GATA transcription factors GLN3 and GAT1 link TOR to salt stress in saccharomyces cerevisiae. J. Biol. Chem., 276, 34441-34444.
66. Weisman, R. and Choder, M. (2001) The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine. J. Biol. Chem., 276, 7027-7032.
67. Vaahtomeri, K., Ventela, E., Laajanen, K., Katajisto, P., Wipff, P.J., Hinz, B., Vallenius, T., Tiainen, M. and Makela, T.P. (2008) Lkb1 is required for TGFbeta-mediated myofibroblast differentiation. J. Cell. Sci., 121, 3531-3540.
68. Djouder, N., Tuerk, R.D., Suter, M., Salvioni, P., Thali, R.F., Scholz, R., Vaahtomeri, K., Auchli, Y., Rechsteiner, H., Brunisholz, R.A. et al. (2010) PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO J., 29, 469-481.
69. Bjorklund, M.A., Vaahtomeri, K., Peltonen, K., Viollet, B., Makela, T.P., Band, A.M. and Laiho, M. (2010) Non-CDK-bound p27 (p27(NCDK)) is a marker for cell stress and is regulated through the Akt/PKB and AMPK-kinase pathways. Exp. Cell Res., 316, 762-774.
70. Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U. and Speed, T.P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
71. Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article 3.
72. Shim, E.H., Kim, J.I., Bang, E.S., Heo, J.S., Lee, J.S., Kim, E.Y., Lee, J.E., Park, W.Y., Kim, S.H., Kim, H.S. et al. (2002) Targeted disruption of hsp70.1 sensitizes to osmotic stress. EMBO Rep., 3, 857-861.
73. Haussinger, D. (1996) The role of cellular hydration in the regulation of cell function. Biochem. J., 313, 697-710.
74. Corradetti, M.N., Inoki, K. and Guan, K.L. (2005) The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem., 280, 9769-9772.
75. Nilsson, I., Rolny, C., Wu, Y., Pytowski, B., Hicklin, D., Alitalo, K., Claesson-Welsh, L. and Wennstrom, S. (2004) Vascular endothelial growth factor receptor-3 in hypoxia-induced vascular development. FASEB J., 18, 1507-1515.
76. Lo, P.K., Chen, J.Y., Tang, P.P., Lin, J., Lin, C.H., Su, L.T., Wu, C.H., Chen, T.L., Yang, Y. and Wang, F.F. (2001) Identification of a mouse thiamine transporter gene as a direct transcriptional target for p53. J. Biol. Chem., 276, 37186-37193.
77. Nishimura, K., Nakatsu, F., Kashiwagi, K., Ohno, H., Saito, T. and Igarashi, K. (2002) Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells, 7, 41-47.
78. Liu, Y.H., Lin, C.Y., Lin, W.C., Tang, S.W., Lai, M.K. and Lin, J.Y. (2008) Up-regulation of vascular endothelial growth factor-D expression in clear cell renal cell carcinoma by CD74: a critical role in cancer cell tumorigenesis. J. Immunol., 181, 6584-6594.
79. Cubas, R., Zhang, S., Li, M., Chen, C. and Yao, Q. (2010) Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol. Cancer., 9, 253.
80. Boya, P., Gonzalez-Polo, R.A., Casares, N., Perfettini, J.L., Dessen, P., Larochette, N., Metivier, D., Meley, D., Souquere, S., Yoshimori, T. et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol., 25, 1025-1040.
81. Blackburn, A.C., Matthaei, K.I., Lim, C., Taylor, M.C., Cappello, J.Y., Hayes, J.D., Anders, M.W. and Board, P.G. (2006) Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol. Pharmacol., 69, 650-657.
82. Wu, P., Blair, P.V., Sato, J., Jaskiewicz, J., Popov, K.M. and Harris, R.A. (2000) Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch. Biochem. Biophys., 381, 1-7.
83. Fox, C.J., Hammerman, P.S. and Thompson, C.B. (2005) The pim kinases control rapamycin-resistant T cell survival and activation. J. Exp. Med., 201, 259-266.
84. Brugarolas, J., Lei, K., Hurley, R.L., Manning, B.D., Reiling, J.H., Hafen, E., Witters, L.A., Ellisen, L.W. and Kaelin, W.G. Jr (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev., 18, 2893-2904.
85. Horak, P., Crawford, A.R., Vadysirisack, D.D., Nash, Z.M., DeYoung, M.P., Sgroi, D. and Ellisen, L.W. (2010) Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc. Natl Acad. Sci. USA, 107, 4675-4680.
86. Tong, E.H., Guo, J.J., Xu, S.X., Mak, K., Chung, S.K., Chung, S.S., Huang, A.L. and Ko, B.C. (2009) Inducible nucleosome depletion at OREBP-binding-sites by hypertonic stress. PLoS One, 4, e8435.
87. Sims, R.J. 3rd, Belotserkovskaya, R. and Reinberg, D. (2004) Elongation by RNA polymerase II: the short and long of it. Genes Dev., 18, 2437-2468.
88. Kahan, B.D. (2008) Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine. Transplant. Proc., 40, S17-S20.
89. Korotchkina, L.G., Leontieva, O.V., Bukreeva, E.I., Demidenko, Z.N., Gudkov, A.V. and Blagosklonny, M.V. (2010) The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging, 2, 344-352.
90. Leontieva, O.V. and Blagosklonny, M.V. (2010) DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging, 2, 924-935.
91. Regazzetti, C., Bost, F., Le Marchand-Brustel, Y., Tanti, J.F. and Giorgetti-Peraldi, S. (2010) Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes. J. Biol. Chem., 285, 5157-5164.
92. Zhou, X., Ferraris, J.D., Cai, Q., Agarwal, A. and Burg, M.B. (2005) Increased reactive oxygen species contribute to high NaCl-induced activation of the osmoregulatory transcription factor TonEBP/OREBP. Am. J. Physiol. Renal Physiol., 289, F377-F385.
93. Zhou, B., Ann, D.K., Li, X., Kim, K.J., Lin, H., Minoo, P., Crandall, E.D. and Borok, Z. (2007) Hypertonic induction of aquaporin-5: novel role of hypoxia-inducible factor-1alpha. Am. J. Physiol. Cell. Physiol., 292, C1280-C1290.
94. Hargreaves, D.C., Horng, T. and Medzhitov, R. (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell, 138, 129-145.
95. Sun, Y., Ge, Y., Drnevich, J., Zhao, Y., Band, M. and Chen, J. (2010) Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J. Cell Biol., 189, 1157-1169.
96. Tsang, C.K., Bertram, P.G., Ai, W., Drenan, R. and Zheng, X.F. (2003) Chromatin-mediated regulation of nucleolar structure and RNA pol I localization by TOR. EMBO J., 22, 6045-6056.
97. Ha, C.W. and Huh, W.K. (2010) Rapamycin increases rDNA stability by enhancing association of Sir2 with rDNA in saccharomyces cerevisiae. Nucleic Acids Res., 39, 1336-1350.
98. Rohde, J.R. and Cardenas, M.E. (2003) The tor pathway regulates gene expression by linking nutrient sensing to histone acetylation. Mol. Cell. Biol., 23, 629-635.
99. Rodriguez, A. and Flemington, E.K. (1999) Transfection-mediated cell-cycle signaling: considerations for transient transfection-based cell-cycle studies. Anal. Biochem., 272, 171-181.
100. Estrada-Gelonch, A., Aramburu, J. and Lopez-Rodriguez, C. (2009) Exclusion of NFAT5 from mitotic chromatin resets its nucleo-cytoplasmic distribution in interphase. PLoS One, 4, e7036.